{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:14:33Z","timestamp":1779909273119,"version":"3.53.1"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.1174","type":"journal-article","created":{"date-parts":[[2005,12,16]],"date-time":"2005-12-16T05:56:17Z","timestamp":1134712577000},"page":"1174-1177","source":"Crossref","is-referenced-by-count":34,"title":["Type 1 Diabetes Mellitus and Drug-resistant Epilepsy: Presence of High Titer of Anti-Glutamic Acid Decarboxylase Autoantibodies in Serum and Cerebrospinal Fluid"],"prefix":"10.2169","volume":"44","author":[{"given":"Takanobu","family":"YOSHIMOTO","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"DOI","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"FUKAI","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"IZUMIYAMA","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"WAGO","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"MINAMI","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"UCHIMURA","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"HIRATA","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Soghomonian J, Martin DL. Two isoforms of glutamate decarboxylase: why? Trends Biochem Sci <b>19<\/b>: 500-505, 1998.","DOI":"10.1016\/S0165-6147(98)01270-X"},{"issue":"5","key":"2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/j.1460-2075.1991.tb08069.x","volume":"10","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0261-4189","issn-type":"print"},{"issue":"2","key":"3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1471-4159.1990.tb01882.x","volume":"54","year":"1990","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411243312107"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Seissler J, Amann J, Mauch L, et al. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest <b>92<\/b>: 1394-1399, 1993.","DOI":"10.1172\/JCI116714"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jun HS, Khil LY, Yoon JW. Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes. Cell Mol Life Sci <b>59<\/b>: 1892-1901, 2002.","DOI":"10.1007\/PL00012512"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med <b>322<\/b>: 1555-1560, 1990.","DOI":"10.1056\/NEJM199005313222202"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dalakas MC, Li M, Fujii M, Jacobowitz DM. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology <b>57<\/b>: 780-784, 2001.","DOI":"10.1212\/WNL.57.5.780"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci <b>23<\/b>: 145-151, 2002.","DOI":"10.1007\/s100720200055"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol <b>58<\/b>: 225-230, 2001.","DOI":"10.1001\/archneur.58.2.225"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Saiz A, Arpa J, Sagasta A, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology <b>49<\/b>: 1026-1030, 1997.","DOI":"10.1212\/WNL.49.4.1026"},{"issue":"2","key":"12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1507\/endocrj.48.261","volume":"48","author":"IWASAKI H","year":"2001","ISSN":"https:\/\/id.crossref.org\/issn\/0918-8959","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nemni R, Braghi S, Natali-Sora MG, et al. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol <b>36<\/b>: 665-667, 1994.","DOI":"10.1002\/ana.410360419"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet <b>352<\/b>: 457, 1998.","DOI":"10.1016\/S0140-6736(05)79192-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Peltola J, Kulmala P, Isojarvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology <b>55<\/b>: 46-50, 2000.","DOI":"10.1212\/WNL.55.1.46"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci <b>175<\/b>: 40-44, 2000.","DOI":"10.1016\/S0022-510X(00)00272-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol <b>44<\/b>: 194-201, 1998.","DOI":"10.1002\/ana.410440209"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med <b>2<\/b>: 148-153, 1996.","DOI":"10.1038\/nm0296-148"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Link H, Tibbling G. Principles of albumin and IgG analysis in neurological disorders III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest <b>37<\/b>: 397-401, 1997.","DOI":"10.3109\/00365517709091498"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Bjork E, Velloso LA, Kampe O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes <b>43<\/b>: 161-165, 1994.","DOI":"10.2337\/diab.43.1.161"},{"issue":"2","key":"21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.156.2.818","volume":"156","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/11\/44_11_1174\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T22:40:30Z","timestamp":1683326430000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/11\/44_11_1174\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.1174","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}